| Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection S Sheikh-Mohamed, B Isho, GYC Chao, M Zuo, C Cohen, Y Lustig, ... Mucosal immunology 15 (5), 799-808, 2022 | 177 | 2022 |
| A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, KT Abe, ... Clinical & translational immunology 11 (3), e1380, 2022 | 81 | 2022 |
| Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis K Yau, KT Abe, D Naimark, MJ Oliver, J Perl, JA Leis, S Bolotin, V Tran, ... JAMA network Open 4 (9), e2123622-e2123622, 2021 | 50 | 2021 |
| Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers KT Abe, Q Hu, M Mozafarihashjin, R Samson, K Manguiat, A Robinson, ... medRxiv, 2021.08. 06.21261721, 2021 | 36 | 2021 |
| Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis K Yau, CT Chan, KT Abe, Y Jiang, M Atiquzzaman, SI Mullin, E Shadowitz, ... Cmaj 194 (8), E297-E305, 2022 | 24 | 2022 |
| Assessment of SARS-CoV-2 seropositivity during the first and second viral waves in 2020 and 2021 among Canadian adults X Tang, A Sharma, M Pasic, P Brown, K Colwill, H Gelband, HC Birnboim, ... JAMA Network Open 5 (2), e2146798-e2146798, 2022 | 22 | 2022 |
| A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination SS Mohamed, GYC Chao, B Isho, M Zuo, GR Nahass, ... | 22 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard S Saeed, SF O’Brien, K Abe, QL Yi, B Rathod, J Wang, M Fazel-Zarandi, ... PloS one 16 (9), e0257743, 2021 | 15 | 2021 |
| Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal … S Sheikh-Mohamed, B Isho, GYC Chao, M Zuo, C Cohen, Y Lustig, ... World Health Organization. One year since the emergence of COVID-19 virus …, 2022 | 9 | 2022 |
| The humoral response to the BNT162b2 vaccine in hemodialysis patients K Yau, KT Abe, D Naimark, MJ Oliver, J Perl, JA Leis, S Bolotin, V Tran, ... medRxiv, 2021.05. 24.21257425, 2021 | 7 | 2021 |
| COVID symptoms, seroprevalence, and mortality during the first wave of SARS-CoV-2 in Canada X Tang, A Sharma, M Pasic, K Colwill, C Birnboim, N Nagelkerke, ... | 7 | 2021 |
| Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 SJ Drews, KT Abe, Q Hu, R Samson, AC Gingras, K Colwill, B Rathod, ... Transfusion 62 (1), 37-43, 2022 | 6 | 2022 |
| SARS-CoV-2 seroprevalence during the first and second pandemic waves in Canada X Tang, A Sharma, M Pasic, P Brown, K Colwill, H Gelband, C Birnboim, ... | 4 | 2021 |
| A" Made-in-Canada" serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination (preprint) K Colwill, Y Galipeau, M Stuible, C Gervais, C Arnold, B Rathod, KT Abe, ... | 4 | 2021 |
| Omicron variant BA. 1, BA. 5, BQ. 1.1, and XBB. 1.5 Neutralizing Antibodies Following BNT162b2 BA. 4/5 versus mRNA-1273 BA. 1 Bivalent Vaccination M Hladunewich, K Yau, A Kurtesi, F Qi, M Delgado-Brand, T Tursun, Q Hu, ... | | 2023 |
| mRNA vaccine-induced IgA protect against SARS-CoV-2 breakthrough infection S Sheikh-Mohamed, B Isho, GYC Chao, M Zuo, C Cohen, Y Lustig, ... medRxiv, 2021.08. 01.21261297, 2021 | | 2021 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard (preprint) S Saeed, SF O'Brein, K Abe, QL Yi, B Rathod, J Wang, M Fazel-Zarandi, ... | | 2021 |
| A mucosal antibody response is induced by intra-muscular SARS-CoV-2 mRNA vaccination (preprint) SS Mohamed, GYC Chao, B Isho, M Zuo, GR Nahass, ... | | 2021 |
| Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers (preprint) KT Abe, Q Hu, M Mozafarihashjin, R Samson, K Manguiat, A Robinson, ... | | 2021 |
